Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2006-11-13
pubmed:abstractText
BCL-2 proteins are critical for cell survival and are overexpressed in many tumors. ABT-737 is a small-molecule BH3 mimetic that exhibits single-agent activity against lymphoma and small-cell lung cancer in preclinical studies. We here report that ABT-737 effectively kills acute myeloid leukemia blast, progenitor, and stem cells without affecting normal hematopoietic cells. ABT-737 induced the disruption of the BCL-2/BAX complex and BAK-dependent but BIM-independent activation of the intrinsic apoptotic pathway. In cells with phosphorylated BCL-2 or increased MCL-1, ABT-737 was inactive. Inhibition of BCL-2 phosphorylation and reduction of MCL-1 expression restored sensitivity to ABT-737. These data suggest that ABT-737 could be a highly effective antileukemia agent when the mechanisms of resistance identified here are considered.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/ABT-737, http://linkedlifedata.com/resource/pubmed/chemical/Biphenyl Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Nitrophenols, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/bcl-2 Homologous Antagonist-Killer..., http://linkedlifedata.com/resource/pubmed/chemical/bcl-2-Associated X Protein, http://linkedlifedata.com/resource/pubmed/chemical/myeloid cell leukemia sequence 1...
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1535-6108
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
375-88
pubmed:dateRevised
2008-7-9
pubmed:meshHeading
pubmed-meshheading:17097560-Animals, pubmed-meshheading:17097560-Apoptosis, pubmed-meshheading:17097560-Biphenyl Compounds, pubmed-meshheading:17097560-Cell Line, pubmed-meshheading:17097560-Dimerization, pubmed-meshheading:17097560-Drug Resistance, Neoplasm, pubmed-meshheading:17097560-Hematopoietic Stem Cells, pubmed-meshheading:17097560-Humans, pubmed-meshheading:17097560-Leukemia, Myeloid, Acute, pubmed-meshheading:17097560-Mice, pubmed-meshheading:17097560-Neoplasm Proteins, pubmed-meshheading:17097560-Nitrophenols, pubmed-meshheading:17097560-Piperazines, pubmed-meshheading:17097560-Protein Conformation, pubmed-meshheading:17097560-Protein Structure, Tertiary, pubmed-meshheading:17097560-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:17097560-RNA, Small Interfering, pubmed-meshheading:17097560-Recombinant Fusion Proteins, pubmed-meshheading:17097560-Sulfonamides, pubmed-meshheading:17097560-bcl-2 Homologous Antagonist-Killer Protein, pubmed-meshheading:17097560-bcl-2-Associated X Protein
pubmed:year
2006
pubmed:articleTitle
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.
pubmed:affiliation
Section of Molecular Hematology and Therapy, Department of Blood and Marrow Transplantation, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural